Abstract The GHRP-6 10mg peptide pen offers a high-capacity, concentrated solution of the first-generation Growth Hormone Secretagogue (GHS). As a potent synthetic analogue of Met-enkephalin, GHRP-6 is the definitive “Ghrelin-mimetic” in research, characterized by its non-selective agonism of the GHS-R1a receptor. While it drives significant growth hormone release, its primary utility in modern research lies in its potent activation of hypothalamic orexigenic pathways and gastric cholinergic neurons. This 10mg formulation is specifically engineered for longitudinal studies requiring sustained daily administration, such as chronic cachexia reversal, feed-refusal models, or large-animal gastrointestinal motility protocols where lower-volume reagents are insufficient.

Mechanism and Research Interest

Primary Biological Pathway: Hyperphagia and Energy Balance GHRP-6 is the reference standard for inducing hyperphagia (extreme hunger). It binds with high affinity to GHS-R1a receptors on Neuropeptide Y (NPY) and Agouti-Related Protein (AgRP) neurons in the arcuate nucleus. This activation overrides leptin-mediated satiety signals. Research utilizing the 10mg pen is critical for long-term “re-feeding” studies, where researchers must maintain a consistent orexigenic stimulus over weeks to reverse catabolic wasting in models of sarcopenia or chemotherapy-induced anorexia.

Secondary Research Finding: Gastric Prokinetic Action GHRP-6 is a powerful prokinetic agent that accelerates gastric emptying and intestinal transit via the vagal cholinergic pathway. The 10mg formulation is utilized in high-throughput gastroenterology screens to test efficacy against opioid-induced bowel dysfunction or diabetic gastroparesis. The high concentration allows for the delivery of effective systemic doses even in models with compromised absorption or rapid metabolic clearance.

Tertiary Research Finding: Broad-Spectrum GH Release While less selective than Ipamorelin, GHRP-6 remains a potent secretagogue. It amplifies the natural GHRH signal, creating a massive pulse of Growth Hormone. The 10mg pen is often used in “synergy stacks” (combined with GHRH analogues) to investigate the maximal secretory reserve of the pituitary gland. It serves as a positive control for GH release in assays where the specificity of side effects (like cortisol release) is a secondary concern to the magnitude of the anabolic signal.

Long-term Genomic and Safety Observations A key aspect of GHRP-6 research is its “off-target” profile. At saturation doses, it stimulates ACTH and Prolactin. Genomic studies utilizing the 10mg dose focus on the chronic impact of this broad-spectrum stimulation, specifically monitoring the adrenal cortex for hypertrophy and the pituitary for lactotroph hyperplasia during prolonged exposure.

Product Specifications

• Purity: Validated at >98+% via High-Performance Liquid Chromatography (HPLC). We strictly control the synthesis to ensure the peptide is free from D-isomer deletion by-products, which can alter the receptor binding kinetics.

• Appearance: The 3ml pen contains a clear, colourless, sterile liquid.

• Precision: The pen delivery system ensures accurate volumetric dosing. The 10mg concentration allows for the administration of higher molar loads (e.g., 200-300mcg) in small volumes, reducing the fluid burden on test subjects during multi-dose daily protocols.

• Storage: The product must be stored at 2∘C to 8∘C.

Storage and Shipping Guidelines

Refrigeration and Shelf Life The GHRP-6 10mg Pen contains a concentrated peptide solution that requires refrigeration (2∘C to 8∘C). The shelf life is 12 months in the sealed state. Once the pen is accessed, the bacteriostatic environment preserves the solution for 28 days. Researchers should note that the 10mg concentration is physically robust, but temperature fluctuations can still degrade the Trp-Ala bond; strict cold-chain maintenance is required.

Shipping Stability We utilize medical-grade thermal packaging. The peptide is stable for up to 72 hours at ambient UK temperatures. However, to ensure the highest fidelity for receptor interaction studies, we recommend selecting the fastest available shipping option.

Freezing Warning Do not freeze. Freezing can cause the peptide to precipitate, leading to “hot spots” of concentration. Using a non-homogenous solution in metabolic studies will result in erratic food intake data, invalidating the experiment. A frozen pen should be discarded.

Why Choose the Peptide Pro 3ml Pen Format?

The GHRP-6 10mg Pen is the definitive tool for Chronic Catabolic and Motility Research. Standard 5mg vials are often insufficient for longitudinal studies involving larger cohorts or higher species (e.g., lagomorphs/canines), necessitating frequent vial changes and increasing variability.

Our 10mg pen provides a high-capacity, sterile source. It supports aggressive dosing regimens required to overcome profound anorexia or gastroparesis, ensuring that the pharmacological stimulus remains constant throughout the duration of the study.

For researchers requiring reduced side-effect profiles, we recommend examining:

• Ipamorelin 10mg: (For pure GH release without hunger or cortisol stimulation).

• GHRP-2 10mg: (For higher GH potency with reduced hunger signalling).

Disclaimer

This product is strictly for Research Use Only (RUO). It is not intended for human consumption, injection (e.g., for appetite enhancement, bodybuilding, or treating gastroparesis), therapeutic use, or diagnostic procedures. The information provided is for educational and scientific reference only. Purchase is restricted to verified research institutions and qualified individuals. Any evidence of intended misuse for human application will result in immediate order cancellation and blacklisting, in compliance with UK research chemical regulations.